The guinea pig as a model of infectious diseases

Comparative Medicine

Volumn 58, Issue 4, 2008, Pages 324-340

  Padilla Carlin, Danielle J ^a   McMurray, David N ^b   Hickey, Anthony J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD1 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; COPOLYMER; CYTOKINE; GAMMA INTERFERON; GLUTAMIC ACID; HAPTEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 8; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; PENICILLIN G; POLYARGININE; POLYLYSINE; PROTEIN P35; PROTEIN P40; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANTIBODY TITER; ANTIGEN RECOGNITION; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHLAMYDIA; CHLAMYDIASIS; COMPLEX FORMATION; CONJUGATION; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DISEASE TRANSMISSION; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION; GUINEA PIG; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOREGULATION; INFECTION; INFECTION SENSITIVITY; LEGIONNAIRE DISEASE; LUNG DISEASE; MACROPHAGE; NONHUMAN; NORTHERN BLOTTING; PATHOGENESIS; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; SOUTHERN BLOTTING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYMPTOMATOLOGY; SYPHILIS; T LYMPHOCYTE; TREPONEMA PALLIDUM; TUBERCULOSIS;

ANIMALS; COMMUNICABLE DISEASES; DISEASE MODELS, ANIMAL; GUINEA PIGS; HUMANS;

EID: 51549109127     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (334)

1. Adachi S, Hashimoto T, Takeyoshi M, Kato H, Iwata H. 2006. Development of a monoclonal antibody-based sandwich ELISA for detection of guinea pig interleukin 2. J Vet Med Sci 68:1281-1287.
2. Allen SS, Cassone L, Lasco TM, McMurray DN. 2004. Effect of neutralizing transforming growth factor β1 on the immune response against Mycobacterium tuberculosis in guinea pigs. Infect Immun 72:1358-1363.
3. Allen SS, McMurray DN. 2003. Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs. Infect Immun 71:4271-4277.
4. Antczak DF. 1982. Structure and function of the major histocompatibility complex in domestic animals. J Am Vet Med Assoc 181:1030-1036.
5. Auerbach HS, Lalande ME, Latt S, Colten HR. 1983. Isolation of guinea pig macrophages bearing surface C4 by fluorescence-activated cell sorting: correlation between surface C4 antigen and C4 protein secretion. J Immunol 131:2420-2426.
6. Baker-Zander SA, Hook EW 3rd, Bonin P, Handsfield HH, Lukehart SA. 1985. Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans. J Infect Dis 151:264-272.
7. Barron AL, Menna JH, Moses EB, Rank RG, Ryu H, White HJ. 1989. Response of guinea pigs to intravaginal inoculation with guinea pig cytomegalovirus. Sex Transm Dis 16:41-46.
8. Barron AL, Pasley JN, Rank RG, White HJ, Mrak RE. 1988. Chlamydial salpingitis in female guinea pigs receiving oral contraceptives. Sex Transm Dis 15:169-173.
9. Barron AL, White HJ, Rank RG, Soloff BL. 1979. Target tissues associated with genital infection of female guinea pigs by the chlamydial agent of guinea pig inclusion conjunctivitis. J Infect Dis 139:60-68.
10. Bartow RA, McMurray DN. 1989. Vaccination with Mycobacterium bovis BCG affects the distribution of Fc receptor-bearing T lymphocytes in experimental pulmonary tuberculosis. Infect Immun 57:1374-1379.
11. Bartow RA, McMurray DN. 1990. Erythrocyte receptor (CD2)-bearing T lymphocytes are affected by diet in experimental pulmonary tuberculosis. Infect Immun 58:1843-1847.
12. Bartow RA, McMurray DN. 1998. Lymphocytes expressing Fc gamma receptors suppress antigen-induced proliferation in cells from guinea pigs infected with virulent Mycobacterium tuberculosis. Cell Immunol 184:51-57.
13. Basaraba RJ, Dailey DD, McFarland CT, Shanley CA, Smith EE, McMurray DN, Orme IM. 2006. Lymphadenitis as a major element of disease in the guinea pig model of tuberculosis. Tuberculosis (Edinb) 86:386-394.
14. Baskerville A, Conlan JW, Ashworth LA, Dowsett AB. 1986. Pulmonary damage caused by a protease from Legionella pneumophila. Br J Exp Pathol 67:527-536.
15. Baskerville A, Fitzgeorge RB, Broster M, Hambleton P, Dennis PJ. 1981. Experimental transmission of Legionnaires' disease by exposure to aerosols of Legionella pneumophila. Lancet 2:1389-1390.
16. Batteiger BE, Rank RG. 1987. Analysis of the humoral immune response to chlamydial genital infection in guinea pigs. Infect Immun 55:1767-1773.
17. Batteiger BE, Rank RG, Bavoil PM, Soderberg LS. 1993. Partial protection against genital reinfection by immunization of guinea pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J Gen Microbiol 139:2965-2972.
18. Baughn RE. 1986. Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum. Infect Immun 54:456-464.
19. Baughn RE, McNeely MC, Jorizzo JL, Musher DM. 1986. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis. J Immunol 136:1406-1414.
20. Baughn RE, Wicher V, Jakubowski A, Wicher K. 1987. Humoral response in Treponema pallidum-infected guinea pigs. II. Circulating immune complexes and autoimmune responses. J Immunol 138:4435-4440.
21. Baughn RE, Wicher V, Wicher K. 1992. Production of rheumatoid factor in adoptively immune guinea pigs after challenge with Treponema pallidum. Immunology 76:548-552.
22. Berendt RF, Young HW, Allen RG, Knutsen GL. 1980. Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila. J Infect Dis 141:186-192.
23. Berger KH, Merriam JJ, Isberg RR. 1994. Altered intracellular targeting properties associated with mutations in the Legionella pneumophila dotA gene. Mol Microbiol 14:809-822.
24. Bitter-Suermann D, Hoffmann T, Burger R, Hadding U. 1981. Linkage of total deficiency of the second component (C2) of the complement system and of genetic C2 polymorphism to the major histocompatibility complex of the guinea pig. J Immunol 127:608-612.
25. Bjornson AB, Bjornson HS, Lincoln NA, Altemeier WA. 1984. Relative roles of burn injury, wound colonization, and wound infection in induction of alterations of complement function in a guinea pig model of burn injury. J Trauma 24:106-115.
26. Blander SJ, Horwitz MA. 1989. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. J Exp Med 169:691-705.
27. Blander SJ, Horwitz MA. 1991. Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila. J Clin Invest 87:1054-1059.
28. Blander SJ, Horwitz MA. 1993. Major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires' disease. J Clin Invest 91:717-723.
29. Blander SJ, Szeto L, Shuman HA, Horwitz MA. 1990. An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease. J Clin Invest 86:817-824.
30. Blaser J, Vergeres P, Widmer AF, Zimmerli W. 1995. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother 39:1134-1139.
31. Bluestein HG, Ellman L, Green I, Benacerraf B. 1971. Specific immune response genes of the guinea pig. 3. Linkage of the GA and GT immune response genes to histocompatibility genotypes in inbred guinea pigs. J Exp Med 134:1529-1537.
32. Bluestein HG, Green I, Benacerraf B. 1971. Specific immune response genes of the guinea pig. I. Dominant genetic control of immune responsiveness to copolymers of L-glutamic acid and L-alanine and L-glutamic acid and L-tyrosine. J Exp Med 134:458-470.
33. Bluestein HG, Green I, Benacerraf B. 1971. Specific immune response genes of the guinea pig. II. Relationship between the poly-L-lysine gene and the genes controlling immune responsiveness to copolymers of L-glutamic acid and L-alanine and L-glutamic acid and L-tyrosine in random-bred Hartley guinea pigs. J Exp Med 134:471-481.
34. Bluestein HG, Green I, Maurer PH, Benacerraf B. 1972. Specific immune response genes of the guinea pig. V. Influence of the GA and GT immune response genes on the specificity of cellular and humoral immune responses to a terpolymer of L-glutamic acid, L-alanine, and L-tyrosine. J Exp Med 135:98-109.
35. Boon RJ, Beale AS, Sutherland R. 1985. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection. J Antimicrob Chemother 16:519-526.
36. Bos JD, Hamerlinck F, Cormane RH. 1980. Antitreponemal IgE in early syphilis. Br J Vener Dis 56:20-25.
37. Bouchenaki N, Vaudaux PE, Huggler E, Waldvogel FA, Lew DP. 1990. Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin. Antimicrob Agents Chemother 34:21-24.
38. Brade V, Cook CT, Shin HS, Mayer MM. 1972. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine-rich β glycoprotein (GBG or factor B). J Immunol 109:1174-1181.
39. Brade V, Nicholson A, Lee GD, Mayer MM. 1974. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics. J Immunol 112:1845-1854.
40. Breiman RF, Horwitz MA. 1987. Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens. J Exp Med 165:799-811.
41. Burger R, Clement L, Schroer J, Chiba J, Shevach EM. 1981. Monoclonal antibodies to guinea pig Ia antigens. I. Production, serologic, and immunochemical characterization. J Immunol 126:32-37.
42. Burger R, Reske K, Mauer U, von Steldern D, Husmann M. 1983. Identification and characterization of gp TFA1, a guinea pig T cell surface antigen associated with T cell function. J Immunol 131:1350-1355.
43. Burger R, Scher I, Sharrow SO, Shevach EM. 1984. Nonactivated guinea pig T cells and thymocytes express Ia antigens: FACS analysis with alloantibodies and monoclonal antibodies. Immunology 51:93-102.
44. Burger R, Schrod L, Schaefer H. 1986. Functionally relevant membrane proteins of human and guinea-pig T lymphocytes. Mol Immunol 23:1149-1156.
45. Burger R, Shevach EM. 1980. Monoclonal antibodies to guinea pig Ia antigens. II. Effect on alloantigen-, antigen-, and mitogen-induced T lymphocyte proliferation in vitro. J Exp Med 152:1011-1023.
46. Cagni A, Chuard C, Vaudaux PE, Schrenzel J, Lew DP. 1995. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 39:1655-1660.
47. Campbell EM, Proudfoot AE, Yoshimura T, Allet B, Wells TN, White AM, Westwick J, Watson ML. 1997. Recombinant guinea pig and human RANTES activate macrophages but not eosinophils in the guinea pig. J Immunol 159:1482-1489.
48. Catusse J, Faye P, Loillier B, Cremers B, Franck RM, Luccarini JM, Pruneau D, Paquet JL. 2003. Cloning and characterization of guinea pig interleukin 8 receptor. Biochem Pharmacol 66:1171-1180.
49. Cegielski JP, McMurray DN. 2004. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 8:286-298.
50. Chiba J, Egashira Y. 1978. Specific immune response genes of new inbred strains of guinea pigs. Jpn J Med Sci Biol 31:425-430.
51. Chiba J, Otokawa M, Nakagawa M, Egashira Y. 1978. Serological studies on the major histocompatibility complex of new inbred strains of the guinea pig. Microbiol Immunol 22:545-555.
52. Cho H, Lasco TM, Allen SS, Yoshimura T, McMurray DN. 2005. Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin 12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect Immun 73:1367-1376.
53. Cho H, McMurray DN. 2005. Neutralization of tumor necrosis factor α suppresses antigen-specific type 1 cytokine responses and reverses the inhibition of mycobacterial survival in cocultures of immune guinea pig T lymphocytes and infected macrophages. Infect Immun 73:8437-8441.
54. Cho H, McMurray DN. 2007. Recombinant guinea pig TNFα enhances antigen-specific type 1 T lymphocyte activation in guinea pig splenocytes. Tuberculosis (Edinb) 87:87-93.
55. Chuard C, Rohner P, Dunand V, Auckenthaler R, Lew DP. 1992. In vitro and in vivo evaluation of the antistaphylococcal activity of S-5556, a new 16-membered macrolide. J Antimicrob Chemother 30:327-337.
56. Claman HN. 1972. Corticosteroids and lymphoid cells. N Engl J Med 287:388-397.
57. Conlan JW, Baskerville A, Ashworth LA. 1986. Separation of Legionella pneumophila proteases and purification of a protease which produces lesions like those of Legionnaires' disease in guinea pig lung. J Gen Microbiol 132:1565-1574.
58. Costerton JW, Geesey GG, Cheng KJ. 1978. How bacteria stick. Sci Am 238:86-95.
59. Cutler RR. 1979. Relationship between antibiotic resistance, the production of 'virulence factors', and virulence for experimental animals in Staphylococcus aureus. J Med Microbiol 12:55-62.
60. D'Erchia AM, Gissi C, Pesole G, Saccone C, Arnason U. 1996. The guinea pig is not a rodent. Nature 381:597-600.
61. Dai G, McMurray DN. 1998. Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs. Infect Immun 66:3562-3568.
62. Dannenberg AM Jr, Rook GAW. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage activating immune responses-dual mechanisms that control bacillary multiplication. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington (DC): American Society for Microbiology.
63. Darville T, Andrews CW Jr, Rank RG. 2000. Does inhibition of tumor necrosis factor α affect chlamydial genital tract infection in mice and guinea pigs? Infect Immun 68:5299-5305.
64. Darville T, Laffoon KK, Kishen LR, Rank RG. 1995. Tumor necrosis factor α activity in genital tract secretions of guinea pigs infected with chlamydiae. Infect Immun 63:4675-4681.
65. Dascher CC, Hiromatsu K, Naylor JW, Brauer PP, Brown KA, Storey JR, Behar SM, Kawasaki ES, Porcelli SA, Brenner MB, LeClair KP. 1999. Conservation of a CD1 multigene family in the guinea pig. J Immunol 163:5478-5488.
66. Davis GS, Winn CW Jr, Gump DW, Craighead JM, Beaty HN. 1983. Legionnaires' pneumonia in guinea pigs and rats produced by aerosol exposure. Chest 83:15S-16S.
67. Davis GS, Winn WC Jr, Gump DW, Beaty HN. 1983. The kinetics of early inflammatory events during experimental pneumonia due to Legionella pneumophila in guinea pigs. J Infect Dis 148:823-835.
68. Davis GS, Winn WC Jr, Gump DW, Craighead JE, Beaty HN. 1982. Legionnaires' pneumonia after aerosol exposure in guinea pigs and rats. Am Rev Respir Dis 126:1050-1057.
69. Donlan RM. 2001. Biofilms and device-associated infections. Emerg Infect Dis 7:277-281.
70. Dournon E, Rajagopalan P. 1988. Comparison of spiramycin and erythromycin in the treatment of experimental guinea pig legionellosis. J Antimicrob Chemother 22 Suppl B:69-72.
71. Dournon E, Rajagopalan P, Vilde JL, Pocidalo JJ. 1986. Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis. J Antimicrob Chemother 17 Suppl B:41-48.
72. Edelstein PH. 1991. Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease. Antimicrob Agents Chemother 35:5-9.
73. Edelstein PH. 1995. Antimicrobial chemotherapy for Legionnaires' disease: a review. Clin Infect Dis 21 Suppl 3:S265-S276.
74. Edelstein PH. 1995. Review of azithromycin activity against Legionella spp. Pathol Biol (Paris) 43:569-572.
75. Edelstein PH, Beer KB, DeBoynton ED. 1987. Influence of growth temperature on virulence of Legionella pneumophila. Infect Immun 55:2701-2705.
76. Edelstein PH, Edelstein MA, Higa F, Falkow S. 1999. Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia model. Proc Natl Acad Sci USA 96:8190-8195.
77. Edelstein PH, Hu B, Higa F, Edelstein MA. 2003. lvgA, a novel Legionella pneumophila virulence factor. Infect Immun 71:2394-2403.
78. Edelstein PH, Snitzer JB, Finegold SM. 1982. Isolation of Legionella pneumophila from hospital potable water specimens: comparison of direct plating with guinea pig inoculation. J Clin Microbiol 15:1092-1096.
79. Edlich RF, Tsung MS, Rogers W, Rogers P, Wangensteen OH. 1968. Studies in management of the contaminated wound. I. Technique of closure of such wounds together with a note on a reproducible experimental model. J Surg Res 8:585-592.
80. Eisenstein TK, Tamada R, Meissler J, Flesher A, Oels HC. 1984. Vaccination against Legionella pneumophila: serum antibody correlates with protection induced by heat-killed or acetone-killed cells against intraperitoneal but not aerosol infection in guinea pigs. Infect Immun 45:685-691.
81. Elliott JA, Johnson W, Helms CM. 1981. Ultrastructural localization and protective activity of a high-molecular-weight antigen isolated from Legionella pneumophila. Infect Immun 31:822-824.
82. Ellman L, Green I, Frank M. 1970. Genetically controlled total deficiency of the fourth component of complement in the guinea pig. Science 170:74-75.
83. Ellman L, Green I, Martin WJ, Benacerraf B. 1970. Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci USA 66:322-328.
84. Espevik T, Nissen-Meyer J. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105.
85. Falcieri E, Vaudaux P, Huggler E, Lew D, Waldvogel F. 1987. Role of bacterial exopolymers and host factors on adherence and phagocytosis of Staphylococcus aureus in foreign body infection. J Infect Dis 155:524-531.
86. Farshy CE, Cruce DD, Klein GC, Wilkinson HW, Feeley JC. 1979. Immunoglobulin specificity of the microagglutination test for the Legionnaires' disease bacterium. Ann Intern Med 90:690.
87. Fields BS, Barbaree JM, Shotts EB Jr, Feeley JC, Morrill WE, Sanden GN, Dykstra MJ. 1986. Comparison of guinea pig and protozoan models for determining virulence of Legionella species. Infect Immun 53:553-559.
88. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78-83.
89. Fluckiger U, Ulrich M, Steinhuber A, Doring G, Mack D, Landmann R, Goerke C, Wolz C. 2005. Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect Immun 73:1811-1819.
90. Foster TJ, Hook M. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 6:484-488.
91. Francois P, Tu Quoc PH, Bisognano C, Kelley WL, Lew DP, Schrenzel J, Cramton SE, Gotz F, Vaudaux P. 2003. Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis. FEMS Immunol Med Microbiol 35:135-140.
92. Frank MM. 1995. Animal models for complement deficiencies. J Clin Immunol 15:113S-121S.
93. Freedman AP, Katz SM. 1981. The prevalence of serum antibodies to Legionella pneumophila in patients with chronic pulmonary disease. Am Rev Respir Dis 123:238-239.
94. Friedman H, Widen R, Lee I, Klein T. 1983. Cellular immunity to Legionella pneumophila in guinea pigs assessed by direct and indirect migration inhibition reactions in vitro. Infect Immun 41:1132-1137.
95. Friedman H, Yamamoto Y, Klein TW. 2002. Legionella pneumophila pathogenesis and immunity. Semin Pediatr Infect Dis 13:273-279.
96. Galandiuk S, Wrightson WR, Young S, Myers S, Polk HC Jr. 1997. Absorbable, delayed-release antibiotic beads reduce surgical wound infection. Am Surg 63:831-835.
97. Ganguly R, Durieux MF, Waldman RH. 1976. Macrophage function in vitamin C-deficient guinea pigs. Am J Clin Nutr 29:762-765.
98. Garcia-Contreras L, Sethuraman V, Kazantseva M, Godfrey V, Hickey AJ. 2006. Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig. J Antimicrob Chemother 58:980-986.
99. Geczy A, de Weck AL. 1974. Proceedings: genetic control of sensitization to chemically defined antigens and its relationship to histocompatibility antigens in guinea pigs. Monogr Allergy 8:83-88.
100. Geczy AF. 1977. Histocompatibility antigens and genetic control of the immune response in guinea pigs IV. Specific inhibition of lymphocyte proliferation by auto-anti-idiotypic antibodies. J Exp Med 145:1093-1098.
101. Geczy AF, de Weck AL, Schwartz BD, Shevach EM. 1975. The major histocompatibility complex of the guinea pig. I. Serologic and genetic studies. J Immunol 115:1704-1710.
102. Geisbrecht BV, Nikonenko B, Samala R, Nakamura R, Nacy CA, Sacksteder KA. 2006. Design and optimization of a recombinant system for large-scale production of the MPT64 antigen from Mycobacterium tuberculosis. Protein Expr Purif 46:64-72.
103. Gell PG, Benacerraf B. 1961. Studies on hypersensitivity. IV. The relationship between contact and delayed sensitivity: a study of the specificity of cellular immune reactions. J Exp Med 113:571-585.
104. Goerke C, Fluckiger U, Steinhuber A, Zimmerli W, Wolz C. 2001. Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of α toxin during device-related infection resolved by direct quantitative transcript analysis. Mol Microbiol 40:1439-1447.
105. Gold HS, Moellering RC Jr. 1996. Antimicrobial drug resistance. N Engl J Med 335:1445-1453.
106. Golden MR, Schillinger JA, Markowitz L, St Louis ME. 2000. Duration of untreated genital infections with Chlamydia trachomatis: a review of the literature. Sex Transm Dis 27:329-337.
107. Gonzalez-Juarrero M, Turner OC, Turner J, Marietta P, Brooks JV, Orme IM. 2001. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect Immun 69:1722-1728.
108. Graur D, Hide WA, Li WH. 1991. Is the guinea pig a rodent? Nature 351:649-652.
109. Green I, Inman JK, Benacerraf B. 1970. Genetic control of the immune response of guinea pigs to limiting doses of bovine serum albumin: relationship to the poly-L-lysine gene. Proc Natl Acad Sci USA 66:1267-1274.
110. Green I, Paul WE, Benacerraf B. 1967. A study of the passive transfer of delayed hypersensitivity to DNP-poly-L-lysine and DNP-GL in responder and nonresponder guinea pigs. J Exp Med 126:959-967.
111. Green RL, Scales RW, Kraus SJ. 1976. Increased serum immunoglobulin E concentrations in venereal diseases. Br J Vener Dis 52:257-260.
112. Hambleton P, Bailey NE, Fitzgeorge RB, Baskerville A. 1985. Clinical chemical responses to experimental airborne legionellosis in the guinea pig. Br J Exp Pathol 66:173-183.
113. Hamuro J, Hadding U, Bitter-Suermann D. 1978. Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities. J Immunol 120:438-444.
114. Harvard BIoMa [Internet]. Index of /ftp/pub/assemblies/mammals/ guineaPig/cavPor3. Cambridge (MA): MIT [updated 2008 Feb 12; cited 2008 July 23]. Available from: http://www.broad.mit.edu/ftp/pub/assemblies/mammals/ guineaPig/cavPor3/.
115. Haslov K, Andersen A, Nagai S, Gottschau A, Sorensen T, Andersen P. 1995. Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun 63:804-810.
116. Herndon DN, Wilmore DW, Mason AD Jr. 1978. Development and analysis of a small animal model simulating the human postburn hypermetabolic response. J Surg Res 25:394-403.
117. Higa F, Edelstein PH. 2001. Potential virulence role of the Legionella pneumophila ptsP ortholog. Infect Immun 69:4782-4789.
118. Higashi N, Yoshizuka N, Kobayashi Y. 1995. Phenotypic properties and cytokine production of skin-infiltrating cells obtained from guinea pig delayed-type hypersensitivity reaction sites. Cell Immunol 164:28-35.
119. Higashi N, Yoshizuka N, Ohuchi A, Osawa T, Kobayashi Y. 1995. Involvement of inflammatory cytokines in a delayed-type hypersensitivity reaction. Cell Immunol 161:288-294.
120. Hiromatsu K, Dascher CC, LeClair KP, Sugita M, Furlong ST, Brenner MB, Porcelli SA. 2002. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J Immunol 169:330-339.
121. Hiromatsu K, Dascher CC, Sugita M, Gingrich-Baker C, Behar SM, LeClair KP, Brenner MB, Porcelli SA. 2002. Characterization of guinea-pig group 1 CD1 proteins. Immunology 106:159-172.
122. Horikawa T, Komohara Y, Kiyota E, Terasaki Y, Takagi K, Takeya M. 2006. Detection of guinea pig macrophages by a new CD68 monoclonal antibody, PM-1K. J Mol Histol 37:15-25.
123. Horwitz MA. 1983. Cell-mediated immunity in Legionnaires' disease. J Clin Invest 71:1686-1697.
124. Horwitz MA. 1983. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med 158:2108-2126.
125. Horwitz MA, Maxfield FR. 1984. Legionella pneumophila inhibits acidification of its phagosome in human monocytes. J Cell Biol 99:1936-1943.
126. Horwitz MA, Silverstein SC. 1980. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest 66:441-450.
127. Howard LV, O'Leary MP, Nichols RL. 1976. Animal model studies of genital chlamydial infections. Immunity to reinfection with guinea pig inclusion conjunctivitis agent in the urethra and eye of male guinea pigs. Br J Vener Dis 52:261-265.
128. Howell JM, Bresnahan KA, Stair TO, Dhindsa HS, Edwards BA. 1995. Comparison of effects of suture and cyanoacrylate tissue adhesive on bacterial counts in contaminated lacerations. Antimicrob Agents Chemother 39:559-560.
129. Howell JM, Dhindsa HS, Stair TO, Edwards BA. 1993. Effect of scrubbing and irrigation on staphylococcal and streptococcal counts in contaminated lacerations. Antimicrob Agents Chemother 37:2754-2755.
130. Howell JM, Stair TO, Howell AW, Mundt DJ, Falcone A, Peters SR. 1993. The effect of scrubbing and irrigation with normal saline, povidone iodine, and cefazolin on wound bacterial counts in a guinea pig model. Am J Emerg Med 11:134-138.
131. Husmann LK, Johnson W. 1992. Adherence of Legionella pneumophila to guinea pig peritoneal macrophages, J774 mouse macrophages, and undifferentiated U937 human monocytes: role of Fc and complement receptors. Infect Immun 60:5212-5218.
132. Husmann LK, Johnson W. 1994. Cytotoxicity of extracellular Legionella pneumophila. Infect Immun 62:2111-2114.
133. Igietseme JU, Rank RG. 1991. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect Immun 59:1346-1351.
134. Imamura T, Tanase S, Szmyd G, Kozik A, Travis J, Potempa J. 2005. Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J Exp Med 201:1669-1676.
135. Jakubowski A, Wicher V, Gruhn R, Wicher K. 1987. Natural antibodies to treponemal antigens in four strains of guinea pigs. Immunology 60:281-285.
136. Jeevan A, McFarland CT, Yoshimura T, Skwor T, Cho H, Lasco T, McMurray DN. 2006. Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect Immun 74:213-224.
137. Jeevan A, Yoshimura T, Foster G, McMurray DN. 2002. Effect of Mycobacterium bovis BCG vaccination on interleukin 1β and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria. Infect Immun 70:1245-1253.
138. Jeevan A, Yoshimura T, Lee KE, McMurray DN. 2003. Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination. Infect Immun 71:354-364.
139. Kaiser AB, Kernodle DS. 1998. Synergism between poly-(1-6)-β-D-glucopyranosyl-(1-3)-β-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model. Antimicrob Agents Chemother 42:2449-2451.
140. Kaiser AB, Kernodle DS, Parker RA. 1992. Low-inoculum model of surgical wound infection. J Infect Dis 166:393-399.
141. Katz SM, Habib WA, Hammel JM, Nash P. 1982. Lack of airborne spread of infection by Legionella pneumophila among guinea pigs. Infect Immun 38:620-622.
142. Kaufman T, Lusthaus SN, Sagher U, Wexler MR. 1990. Deep partial skin thickness burns: a reproducible animal model to study burn wound healing. Burns 16:13-16.
143. Kawabata TT, Babcock LS, Gauggel DL, Asquith TN, Fletcher ER, Horn PA, Ratajczak HV, Graziano FM. 1995. Optimization and validation of an ELISA to measure specific guinea pig IgG1 antibody as an alternative to the in vivo passive cutaneous anaphylaxis assay. Fundam Appl Toxicol 24:238-246.
144. Kawahara M, Nakasone T, Honda M. 2002. Dynamics of gamma interferon, interleukin-12 (IL-12), IL-10, and transforming growth factor beta mRNA expression in primary Mycobacterium bovis BCG infection in guinea pigs measured by a real-time fluorogenic reverse transcription-PCR assay. Infect Immun 70:6614-6620.
145. Kawai K, Suzuki S, Tabata Y, Taira T, Ikada Y, Nishimura Y. 2001. Development of an artificial dermis preparation capable of silver sulfadiazine release. J Biomed Mater Res 57:346-356.
146. Kernodle DS, Gates H, Kaiser AB. 1998. Prophylactic antiinfective activity of poly-[1-6]-β-D-glucopyranosyl-[1-3]-β-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection. Antimicrob Agents Chemother 42:545-549.
147. Kernodle DS, Kaiser AB. 1993. Comparative prophylactic efficacy of cefazolin and vancomycin in a guinea pig model of Staphylococcus aureus wound infection. J Infect Dis 168:152-157.
148. Kernodle DS, Kaiser AB. 1993. Efficacy of prophylaxis with β-lactams and β-lactam-β-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model. Antimicrob Agents Chemother 37:702-707.
149. Kernodle DS, Kaiser AB. 1994. Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection. Antimicrob Agents Chemother 38:1325-1330.
150. Kessler CM, Tang Z, Jacobs HM, Szymanski LM. 1997. The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity. Blood 89:4393-4401.
151. Klein TW, Friedman H, Widen R. 1984. Relative potency of virulent versus avirulent Legionella pneumophila for induction of cell-mediated immunity. Infect Immun 44:753-755.
152. Klunner T, Bartels T, Vordermeier M, Burger R, Schafer H. 2001. Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with Bacillus Calmette Guerin. Vaccine 19:1968-1977.
153. Koch R. 1882. Aetiologie der Tuberculose. Berlin Klin Wochenschr 19:221-230.
154. Kraal G, Shiamatey-Koolma R, Hoffer M, Baker D, Scheper R. 1988. Histochemical identification of guinea pig macrophages by monoclonal antibody MR1. Immunology 65:523-528.
155. Kraal G, Twisk A, Tan B, Scheper R. 1986. A surface molecule on guinea pig lymphocytes involved in adhesion and homing. Eur J Immunol 16:1515-1519.
156. Lafond RE, Lukehart SA. 2006. Biological basis for syphilis. Clin Microbiol Rev 19:29-49.
157. Lamm ME, Lisowska-Bernstein B, Green I, Benacerraf B. 1968. Peptide mapping study of anti-DNP-PLL antibodies produced by guinea pigs with and without the PLL gene. Proc Soc Exp Biol Med 127:1139-1141.
158. Lammers R, Henry C, Howell J. 2001. Bacterial counts in experimental, contaminated crush wounds irrigated with various concentrations of cefazolin and penicillin. Am J Emerg Med 19:1-5.
159. Lamont HC, Semine DZ, Leveille C, Nichols RL. 1978. Immunity to vaginal reinfection in female guinea pigs infected sexually with Chlamydia of guinea pig inclusion conjunctivitis. Infect Immun 19:807-813.
160. Lasco TM, Cassone L, Kamohara H, Yoshimura T, McMurray DN. 2005. Evaluating the role of tumor necrosis factor α in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis (Edinb) 85:245-258.
161. Lasco TM, Turner OC, Cassone L, Sugawara I, Yamada H, McMurray DN, Orme IM. 2004. Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect Immun 72:1147-1149.
162. Levine BB, Ojeda A, Benacerraf B. 1963. Basis for the antigenicity of hapten-poly-L-lysine conjugates in random-bred guinea pigs. Nature 200:544-546.
163. Levine BB, Ojeda A, Benacerraf B. 1963. Studies on artificial antigens. III. The genetic control of the immune response to hapten-poly-L-lysine conjugates in guinea pigs. J Exp Med 118:953-957.
164. Limb GA, Brown KA, Wolstencroft RA, Ellis BA, Dumonde DC. 1988. Modulation of Fc and C3b receptor expression on guinea pig macrophages by lymphokines. Clin Exp Immunol 74:171-176.
165. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339:520-532.
166. Luneberg E, Zahringer U, Knirel YA, Steinmann D, Hartmann M, Steinmetz I, Rohde M, Kohl J, Frosch M. 1998. Phase-variable expression of lipopolysaccharide contributes to the virulence of Legionella pneumophila. J Exp Med 188:49-60.
167. Lyons MJ, Yoshimura T, McMurray DN. 2002. Mycobacterium bovis BCG vaccination augments interleukin 8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis. Infect Immun 70:5471-5478.
168. Lyons MJ, Yoshimura T, McMurray DN. 2004. Interleukin (IL) 8 (CXCL8) induces cytokine expression and superoxide formation by guinea pig neutrophils infected with Mycobacterium tuberculosis. Tuberculosis (Edinb) 84:283-292.
169. Mainali ES, McMurray DN. 1998. Protein deficiency induces alterations in the distribution of T-cell subsets in experimental pulmonary tuberculosis. Infect Immun 66:927-931.
170. Maiwald M, Schill M, Stockinger C, Helbig JH, Luck PC, Witzleb W, Sonntag HG. 1995. Detection of Legionella DNA in human and guinea pig urine samples by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis 14:25-33.
171. Mauer-Gross U, von Steldern D, Hadding U, Bitter-Suermann D, Burger R. 1985. Cell surface antigens on the guinea-pig macrophage: identification by monoclonal antibodies and association with the activation state. Immunology 55:519-530.
172. Maurin M, Lepidi H, La Scola B, Feuerstein M, Andre M, Pellissier JF, Raoult D. 1997. Guinea pig model for Staphylococcus aureus native valve endocarditis. Antimicrob Agents Chemother 41:1815-1817.
173. Mazurak VC, Burrell RE, Tredget EE, Clandinin MT, Field CJ. 2007. The effect of treating infected skin grafts with Acticoat on immune cells. Burns 33:52-58.
174. McBride BW, Newell DG. 1989. Production and characterization of monoclonal antibodies directed against guinea pig IgG subclasses. J Immunol Methods 118:193-198.
175. McDade JE, Shepard CC. 1979. Virulent to avirulent conversion of Legionnaires' disease bacterium (Legionella pneumophila)::its effect on isolation techniques. J Infect Dis 139:707-711.
176. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR. 1977. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 297:1197-1203.
177. McMurray DN. 1994. Guinea pig model of tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington (DC): American Society for Microbiology.
178. McMurray DN. 2001. Disease model: pulmonary tuberculosis. Trends Mol Med 7:135-137.
179. McMurray DN. 2007. Personal communication.
180. McMurray DN, Bartow RA. 1992. Immunosuppression and alteration of resistance to pulmonary tuberculosis in guinea pigs by protein undernutrition. J Nutr 122:738-743.
181. McMurray DN, Bartow RA, Mintzer CL. 1990. Protein malnutrition alters the distribution of Fc gamma R+ (T gamma) and Fc mu R+ (T mu) T lymphocytes in experimental pulmonary tuberculosis. Infect Immun 58:563-565.
182. McMurray DN, Collins FM, Dannenberg AM Jr, Smith DW. 1996. Pathogenesis of experimental tuberculosis in animal models. Curr Top Microbiol Immunol 215:157-179.
183. McMurray DN, Mintzer CL, Tetzlaff CL, Carlomagno MA. 1986. The influence of dietary protein on the protective effect of BCG in guinea pigs. Tubercle 67:31-39.
184. Menzies BE, Kourteva Y, Kaiser AB, Kernodle DS. 2002. Inhibition of staphylococcal wound infection and potentiation of antibiotic prophylaxis by a recombinant fragment of the fibronectin-binding protein of Staphylococcus aureus. J Infect Dis 185:937-943.
185. Meurs H, Santing RE, Remie R, van der Mark TW, Westerhof FJ, Zuidhof AB, Bos IS, Zaagsma J. 2006. A guinea pig model of acute and chronic asthma using permanently instrumented and unrestrained animals. Nat Protocols 1:840-847.
186. Miedzobrodzki J, Tadeusiewicz R. 1987. Staphylococcal dermonecrotic reactions in guinea pigs. Int J Biomed Comput 21:67-74.
187. Ming X, Nichols M, Rothenburger S. 2007. In vivo antibacterial efficacy of Monocryl plus antibacterial suture (poliglecaprone 25 with triclosan). Surg Infect (Larchmt) 8:209-214.
188. Miyamoto H, Yoshida S, Taniguchi H, Shuman HA. 2003. Virulence conversion of Legionella pneumophila by conjugal transfer of chromosomal DNA. J Bacteriol 185:6712-6718.
189. Mizobuchi S, Minami J, Jin F, Matsushita O, Okabe A. 1994. Comparison of the virulence of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Microbiol Immunol 38:599-605.
190. Moffat JF, Black WJ, Tompkins LS. 1994. Further molecular characterization of the cloned Legionella pneumophila zinc metalloprotease. Infect Immun 62:751-753.
191. Moffat JF, Edelstein PH, Regula DP Jr, Cirillo JD, Tompkins LS. 1994. Effects of an isogenic Zn-metalloprotease-deficient mutant of Legionella pneumophila in a guinea pig pneumonia model. Mol Microbiol 12:693-705.
192. Morris GK, Patton CM, Feeley JC, Johnson SE, Gorman G, Martin WT, Skaliy P, Mallison GF, Politi BD, Mackel DC. 1979. Isolation of the Legionnaires' disease bacterium from environmental samples. Ann Intern Med 90:664-666.
193. Mount DT, Bigazzi PE, Barron AL. 1972. Infection of genital tract and transmission of ocular infection to newborns by the agent of guinea pig inclusion conjunctivitis. Infect Immun 5:921-926.
194. Mount DT, Bigazzi PE, Barron AL. 1973. Experimental genital infection of male guinea pigs with the agent of guinea pig inclusion conjunctivitis and transmission to females. Infect Immun 8:925-930.
195. Nagaoka I, Ishihara N, Yamashita T. 1994. Characterization of the promoters of the guinea pig neutrophil cationic peptide 1 and 2 genes. FEBS Lett 356:33-38.
196. Nagaoka I, Nonoguchi A, Yamashita T. 1993. Cloning and characterization of the guinea pig neutrophil cationic peptide 1 and 2 genes. DNA Seq 4:123-128.
197. Nagarajan UM, O'Connell C, Rank RG. 2004. Molecular characterization of guinea pig (Cavia porcellus) CD8α and CD8β cDNA. Tissue Antigens 63:184-189.
198. Nakamura T, Sato H, Shimamura T, Koyama J. 1988. The different roles of two distinct Fc gamma receptors on guinea pig macrophages in the phagocytosis of sensitized sheep erythrocytes. J Biochem 104:383-387.
199. Nakamura T, Tamoto K, Maeyama J, Sato H, Shimamura T, Koyama J. 1987. Identification of an Fc receptor for IgG1 and IgG2 on guinea-pig polymorphonuclear leukocytes. Mol Immunol 24:831-837.
200. Neild AL, Roy CR. 2003. Legionella reveal dendritic cell functions that facilitate selection of antigens for MHC class II presentation. Immunity 18:813-823.
201. Neild AL, Roy CR. 2004. Immunity to vacuolar pathogens: what can we learn from Legionella: Cell Microbiol 6:1011-1018.
202. Nelson JL, Alexander JW, Gianotti L, Chalk CL, Pyles T. 1996. High protein diets are associated with increased bacterial translocation in septic guinea pigs. Nutrition 12:195-199.
203. Nicholson A, Austen KF. 1977. Isolation and characterization of guinea pig properidin. J Immunol 118:103-108.
204. Nikaido Y, Yoshida S, Goto Y, Mizuguchi Y, Kuroiwa A. 1989. Macrophage-activating T cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs. Infect Immun 57:3458-3465.
205. Norris SJ. 1993. Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group. Microbiol Rev 57:750-779.
206. O'Brien RJ. 1993. The treatment of tuberculosis. In: Reichmann LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker. p 207-240
207. Ohtani M, Kobayashi Y, Watanabe N. 2004. Gene expression in the elicitation phase of guinea pig DTH and CHS reactions. Cytokine 25:246-253.
208. Onozaki K, Akagawa KS, Haga S, Miura K, Hashimoto T, Tokunaga T. 1983. Role of lymphokines in regulation of macrophage differentiation. Cell Immunol 76:129-136.
209. Orenstein A, Klein D, Kopolovic J, Winkler E, Malik Z, Keller N, Nitzan Y. 1997. The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections. FEMS Immunol Med Microbiol 19:307-314.
210. Orme IM. 2005. Current progress in tuberculosis vaccine development. Vaccine 23:2105-2108.
211. Orme IM. 2005. Mouse and guinea pig models for testing new tuberculosis vaccines. Tuberculosis (Edinb) 85:13-17.
212. Orme IM. 2005. Tuberculosis vaccines: current progress. Drugs 65:2437-2444.
213. Orme IM. 2006. Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine 24:2-19.
214. Orme IM, McMurray DN, Belisle JT. 2001. Tuberculosis vaccine development: recent progress. Trends Microbiol 9:115-118.
215. O'Rourke E, Schweon S. 2007. Syphillis. Still a public health danger. RN 70:26-31, quiz 32.
216. Pal PG, Horwitz MA. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 60:4781-4792.
217. Pasley JN, Rank RG, Hough AJ Jr, Cohen C, Barron AL. 1985. Absence of progesterone effects on chlamydial genital infection in female guinea pigs. Sex Transm Dis 12:155-158.
218. Pasley JN, Rank RG, Hough AJ Jr, Cohen C, Barron AL. 1985. Effects of various doses of estradiol on chlamydial genital infection in ovariectomized guinea pigs. Sex Transm Dis 12:8-13.
219. Patterson TL, Rank RG. 1996. Immunity to reinfection and immunization of male guinea pigs against urethral infection with the agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 23:145-150.
220. Pavia CS. 1986. Enhanced primary resistance to Treponema pallidum infection and increased susceptibility to toxoplasmosis in T-cell-depleted guinea pigs. Infect Immun 53:305-311.
221. Pavia CS. 1986. Transfer of resistance to syphilitic infection from maternal to newborn guinea pigs. Infect Immun 51:365-368.
222. Pavia CS, Niederbuhl CJ. 1985. Acquired resistance and expression of a protective humoral immune response in guinea pigs infected with Treponema pallidum Nichols. Infect Immun 50:66-72.
223. Pavia CS, Niederbuhl CJ. 1985. Adoptive transfer of antisyphilis immunity with lymphocytes from Treponema pallidum-infected guinea pigs. J Immunol 135:2829-2834.
224. Pavia CS, Niederbuhl CJ. 1985. Experimental infection of inbred guinea pigs with Treponema pallidum: development of lesions and formation of antibodies. Genitourin Med 61:75-81.
225. Pavia CS, Niederbuhl CJ, Saunders J. 1985. Antibody-mediated protection of guinea pigs against infection with Treponema pallidum. Immunology 56:195-202.
226. Peck MD, Alexander JW. 1991. Survival in septic guinea pigs is influenced by vitamin E, but not by vitamin C in enteral diets. JPEN J Parenter Enteral Nutr 15:433-436.
227. Pierce CS, Wicher K, Nakeeb S. 1983. Experimental syphilis: guinea pig model. Br J Vener Dis 59:157-168.
228. Platt J, Bucknall RA. 1984. An experimental evaluation of antiseptic wound irrigation. J Hosp Infect 5:181-188.
229. Porcelli SA, Modlin RL. 1999. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 17:297-329.
230. Pre-Ensembl. [Internet]. August 2007. Cambridge (UK):WTSI/EBI; c2008 [cited 2007 August]. Available from: http://pre.ensembl.org/ Cavia_porcellus/index.html.
231. Quinn J, Maw J, Ramotar K, Wenckebach G, Wells G. 1997. Octylcyanoacrylate tissue adhesive versus suture wound repair in a contaminated wound model. Surgery 122:69-72.
232. Rajagopalan-Levasseur P, Lecointe D, Bertrand G, Fay M, Gougerot-Pocidalo MA. 1996. Differential nitric oxide (NO) production by macrophages from mice and guinea pigs infected with virulent and avirulent Legionella pneumophila serogroup 1. Clin Exp Immunol 104:48-53.
233. Raju B, Hoshino Y, Kuwabara K, Belitskaya I, Prabhakar S, Canova A, Gold JA, Condos R, Pine RI, Brown S, Rom WN, Weiden MD. 2004. Aerosolized γ interferon (IFNγ) induces expression of the genes encoding the IFNγ-inducible 10-kDa protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun 72:1275-1283.
234. Rank RG. 1999. Models of immunity. In: Stephens RS, editor. Chlamydia: intracellular biology, pathogenesis, and immunity. Washington (DC): American Society for Microbiology. p. 239-295
235. Rank RG, Barron AL. 1983. Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs. Infect Immun 41:876-879.
236. Rank RG, Barron AL. 1983. Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect Immun 39:463-465.
237. Rank RG, Barron AL. 1987. Specific effect of estradiol on the genital mucosal antibody response in chlamydial ocular and genital infections. Infect Immun 55:2317-2319.
238. Rank RG, Batteiger BE. 1989. Protective role of serum antibody in immunity to chlamydial genital infection. Infect Immun 57:299-301.
239. Rank RG, Batteiger BE, Soderberg LS. 1988. Susceptibility to reinfection after a primary chlamydial genital infection. Infect Immun 56:2243-2249.
240. Rank RG, Batteiger BE, Soderberg LS. 1990. Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes. Infect Immun 58:2599-2605.
241. Rank RG, Bowlin AK, Kelly KA. 2000. Characterization of lymphocyte response in the female genital tract during ascending chlamydial genital infection in the guinea pig model. Infect Immun 68:5293-5298.
242. Rank RG, Bowlin AK, Reed RL, Darville T. 2003. Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose. Infect Immun 71:6148-6154.
243. Rank RG, Sanders MM, Patton DL. 1995. Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 22:48-54.
244. Rank RG, White HJ, Barron AL. 1979. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 26:573-579.
245. Rank RG, White HJ, Hough AJ Jr, Pasley JN, Barron AL. 1982. Effect of estradiol on chlamydial genital infection of female guinea pigs. Infect Immun 38:699-705.
246. Rank RG, White HJ, Soloff BL, Barron AL. 1981. Cystitis associated with chlamydial infection of the genital tract in male guinea pigs. Sex Transm Dis 8:203-210.
247. Robinson AJ, Ridgway GL. 1996. Modern diagnosis and management of genital Chlamydia trachomatis infection. Br J Hosp Med 55:388-393.
248. Roche PW, Triccas JA, Winter N. 1995. BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol 3:397-401.
249. Sato M, Nakamura T, Koyama J. 1987. Different abilities of two distinct Fcγ receptors on guinea pig polymorphonuclear leukocytes to trigger the arachidonic acid metabolic cascade. FEBS Lett 224:29-32.
250. 2 generation. Mol Immunol 25:205-211.
251. Scarozza AM, Ramsingh AI, Wicher V, Wicher K. 1998. Spontaneous cytokine gene expression in normal guinea pig blood and tissues. Cytokine 10:851-859.
252. Schaad HJ, Chuard C, Vaudaux P, Waldvogel FA, Lew DP. 1994. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 38:1703-1710.
253. Schachter J, Cles LD, Ray RM, Hesse FE. 1983. Is there immunity to chlamydial infections of the human genital tract? Sex Transm Dis 10:123-125.
254. Schrod L, Schaefer H, Burger R. 1986. Characterization of a T lymphocyte membrane protein involved in T cell function: its contribution to T cell recognition or cellular interaction. Immunology 57:533-538.
255. Senn MM, Giachino P, Homerova D, Steinhuber A, Strassner J, Kormanec J, Fluckiger U, Berger-Bachi B, Bischoff M. 2005. Molecular analysis and organization of the σB operon in Staphylococcus aureus. J Bacteriol 187:8006-8019.
256. Seya T, Okada M, Hazeki K, Nagasawa S. 1991. Regulatory system of guinea pig complement C3b: tests for compatibility of guinea pig factors H and I with human factors. Mol Immunol 28:375-382.
257. Sheffield CW, Sessler DI, Hunt TK, Scheuenstuhl H. 1994. Mild hypothermia during halothane-induced anesthesia decreases resistance to Staphylococcus aureus dermal infection in guinea pigs. Wound Repair Regen 2:48-56.
258. Shimokawa Y, Harita S, Hayashi H. 1984. Lymphocyte Chemotaxis in inflammation. VII. Isolation and purification of chemotactic factors for T lymphocytes from PPD-induced delayed hypersensitivity skin reaction site in the guinea pig. Immunology 51:275-285.
259. Shimokawa Y, Harita S, Higuchi Y, Hayashi H. 1982. Lymphocyte Chemotaxis in inflammation. III. Demonstration of lymphocyte chemotactic activity in extract from PPD-induced delayed hypersensitivity skin reaction site in the guinea pig. Br J Exp Pathol 63:355-361.
260. Shimokawa Y, Harita S, Higuchi Y, Hayashi H. 1982. Lymphocyte Chemotaxis in inflammation. IV. Isolation of lymphocyte chemotactic factors from PPD-induced delayed hypersensitivity skin reaction site in the guinea pig, with special reference to a factor chemotactic for B cells. Br J Exp Pathol 63:362-368.
261. Shimokawa Y, Harita S, Mibu Y, Hayashi H. 1984. Lymphocyte Chemotaxis in inflammation. VIII. Demonstration of lymphocyte chemotactic lymphokines in PPD-induced delayed hypersensitivity skin reaction site in the guinea pig. Immunology 51:287-294.
262. Shiratori I, Matsumoto M, Tsuji S, Nomura M, Toyoshima K, Seya T. 2001. Molecular cloning and functional characterization of guinea pig IL12. Int Immunol 13:1129-1139.
263. Siddiqui SM, Orme IM, Saxena RK. 2000. Efficacy of culture filtrate protein preparations from Indian isolates of M. tuberculosis to activate T cells derived from healthy donors. Int J Tuberc Lung Dis 4:980-987.
264. Singer L, Colten HR, Wetsel RA. 1994. Complement C3 deficiency: human, animal, and experimental models. Pathobiology 62:14-28.
265. Skeiky YA, Sadoff JC. 2006. Advances in tuberculosis vaccine strategies. Nat Rev Microbiol 4:469-476.
266. Skwor TA, Cho H, Cassidy C, Yoshimura T, McMurray DN. 2004. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages. J Leukoc Biol 76:1229-1239.
267. Skwor TA, Sedberry Allen S, Mackie JT, Russell K, Berghman LR, McMurray DN. 2006. BCG vaccination of guinea pigs modulates Mycobacterium tuberculosis-induced CCL5 (RANTES) production in vitro and in vivo. Tuberculosis (Edinb) 86:419-429.
268. Smith DW, McMurray DN, Wiegeshaus EH, Grover AA, Harding GE. 1970. Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs. Am Rev Respir Dis 102:937-949.
269. Smith S, Gantt N, Rowe MI, Lloyd DA. 1989. Dura versus Gore-Tex as an abdominal wall prosthesis in an open and closed infected model. J Pediatr Surg 24:519-521.
270. Soloff BL, Rank RG, Barron AL. 1985. Electron microscopic observations concerning the in vivo uptake and release of the agent of guinea pig inclusion conjunctivitis (Chlamydia psittaci) in guinea pig exocervix. J Comp Pathol 95:335-344.
271. Storch ML, Rothenburger SJ, Jacinto G. 2004. Experimental efficacy study of coated Vicryl plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect (Larchmt) 5:281-288.
272. Stratford AF, Zoutman DE, Davidson JS. 2002. Effect of lidocaine and epinephrine on Staphylococcus aureus in a guinea pig model of surgical wound infection. Plast Reconstr Surg 110:1275-1279.
273. Suarez S, O'Hara P, Kazantseva M, Newcomer CE, Hopfer R, McMurray DN, Hickey AJ. 2001. Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J Antimicrob Chemother 48:431-434.
274. Suarez S, O'Hara P, Kazantseva M, Newcomer CE, Hopfer R, McMurray DN, Hickey AJ. 2001. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model. Pharm Res 18:1315-1319.
275. Takahashi M, Jeevan A, Sawant K, McMurray DN, Yoshimura T. 2007. Cloning and characterization of guinea pig CXCR1. Mol Immunol 44:878-888.
276. Takizawa M, Chiba J, Haga S, Asano T, Yamamoto N, Honda M. 2004. The normalization of guinea pig leukocyte fractions and lymphocyte subsets in blood and lymphoid tissues using a flow cytometric procedure. Exp Anim 53:321-329.
277. Takizawa M, Chiba J, Haga S, Asano T, Yamazaki T, Yamamoto N, Honda M. 2006. Novel two-parameter flow cytometry (MIL4/SSC followed by MIL4/CT7) allows for identification of five fractions of guinea pig leukocytes in peripheral blood and lymphoid organs. J Immunol Methods 311:47-56.
278. Tateda K, Matsumoto T, Ishii Y, Furuya N, Ohno A, Miyazaki S, Yamaguchi K. 1998. Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines. Clin Diagn Lab Immunol 5:401-403.
279. Tominaga M, Sakata A, Ohmura T, Yamashita T, Koyama J, Onoue K. 1990. The structure and expression of the guinea pig Fc receptor for IgG1 and IgG2 (Fcγ1/γ2R). Biochem Biophys Res Commun 168:683-689.
280. Tree JA, Elmore MJ, Javed S, Williams A, Marsh PD. 2006. Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination. Infect Immun 74:1436-1441.
281. Turner OC, Basaraba RJ, Orme IM. 2003. Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis. Infect Immun 71:864-871.
282. Valet G, Jenssen HL, Krefft M, Ruhenstroth-Bauer G. 1981. Flow-cytometric measurements of the transmembrane potential, the surface charge density and the phagocytic activity of Guinea pig macrophages after incubation with lymphokines. Blut 42:379-382.
283. van Voorhis WC, Barrett LK, Nasio JM, Plummer FA, Lukehart SA. 1996. Lesions of primary and secondary syphilis contain activated cytolytic T cells. Infect Immun 64:1048-1050.
284. Vaudaux P, Francois P, Bisognano C, Schrenzel J, Lew DP. 2002. Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 46:1503-1509.
285. Vaudaux P, Suzuki R, Waldvogel FA, Morgenthaler JJ, Nydegger UE. 1984. Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. J Infect Dis 150:546-553.
286. Vogel FR, Klein TW, Specter SC, Hitchings M, Friedman H. 1981. Detection of antibodies to Legionella pneumophila in immune guinea pig serum by solid-phase immunofluorescence. J Clin Microbiol 13:726-729.
287. von Behring E. 1890. Untersuchungen uber das Zustanddekommen der Diphtherie-Immunitat bei Theiren. Dtsch Med Wochenschr 16:1145.
288. Wagner C, Khan AS, Kamphausen T, Schmausser B, Unal C, Lorenz U, Fischer G, Hacker J, Steinert M. 2007. Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix. Cell Microbiol 9:450-462.
289. Ward ME. 1999. Mechanisms of Chlamydia-induced disease. In: Stephens RS, editor. Chlamydia: intracellular biology, pathogenesis, and immunity. Washington (DC): American Society for Microbiology. p. 171-210
290. Washington AE, Gove S, Schachter J, Sweet RL. 1985. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection. J Am Med Assoc 253:2246- 2250.
291. Weeratna R, Stamler DA, Edelstein PH, Ripley M, Marrie T, Hoskin D, Hoffman PS. 1994. Human and guinea pig immune responses to Legionella pneumophila protein antigens OmpS and Hsp60. Infect Immun 62:3454-3462.
292. White HJ, Rank RG, Soloff BL, Barron AL. 1979. Experimental chlamydial salpingitis in immunosuppressed guinea pigs infected in the genital tract with the agent of guinea pig inclusion conjunctivitis. Infect Immun 26:728-735.
293. Wicher K, Abbruscato F, Wicher V, Baughn R, Noordhoek GT. 1996. Target organs of infection in guinea pigs with acquired congenital syphilis. Infect Immun 64:3174-3179.
294. Wicher K, Baughn RE, Wicher V, Nakeeb S. 1992. Experimental congenital syphilis: guinea pig model. Infect Immun 60:271-277.
295. Wicher K, Jakubowski A. 1964. Effect of cortisone on the course of experimental syphilis in the guinea-pig. I. Effect of previously administered cortisone on guinea pigs infected with Treponema pallidum intradermally, intratesticularly, and intravenously. Br J Vener Dis 40:213-216.
296. Wicher K, Jakubowski A, Wicher V. 1987. Humoral response in Treponema pallidum-infected guinea pigs: I. Antibody specificity. Clin Exp Immunol 69:263-270.
297. Wicher K, Miller JN, Urquhart AW, Wicher V. 1989. Treponema pallidum-immobilizing antibodies in guinea pig experimental syphilis. Infect Immun 57:2900-2902.
298. Wicher K, Schouls LM, Wicher V, Van Embden JD, Nakeeb SS. 1991. Immunization of guinea pigs with recombinant TmpB antigen induces protection against challenge infection with Treponema pallidum Nichols. Infect Immun 59:4343-4348.
299. Wicher K, van Embden JD, Schouls LM, Zabek J, Jakubowski A, Wicher V. 1989. Immunogenicity of three recombinant Treponema pallidum antigens examined in guinea pigs. Int Arch Allergy Appl Immunol 89:128-135.
300. Wicher K, Wicher V. 1989. Experimental syphilis in guinea pig. Crit Rev Microbiol 16:181-234.
301. Wicher K, Wicher V, Abbruscato F, Baughn RE. 2000. Treponema pallidum subsp. pertenue displays pathogenic properties different from those of T. pallidum subsp. pallidum. Infect Immun 68:3219-3225.
302. Wicher K, Wicher V, Gruhn RF. 1985. Differences in susceptibility to infection with Treponema pallidum (Nichols) between five strains of guinea pig. Genitourin Med 61:21-26.
303. Wicher K, Wicher V, Jakubowski A, Bartholomew W, Nakeeb S. 1988. Effect of irradiation and depletion of C3-complement component on the course of Treponema pallidum infection in a resistant guinea pig strain. Int Arch Allergy Appl Immunol 86:76-81.
304. Wicher K, Wicher V, Jakubowski A, Gruhn R. 1988. Factors affecting the clinical course of Treponema pallidum infection in guinea pigs. Int Arch Allergy Appl Immunol 85:252-256.
305. Wicher K, Wicher V, Wang MC. 1976. Cellular and humoral immune response to guinea pig infected with Treponema pallidum. Int Arch Allergy Appl Immunol 51:284-297.
306. Wicher K, Zabek J, Wicher V. 1992. Effect of passive in imunization with purified specific or cross-reacting immunoglobulin G antibodies against Treponema pallidum on the course of infection in guinea pigs. Infect Immun 60:3217-3223.
307. Wicher V, Scarozza AM, Ramsingh AI, Wicher K. 1998. Cytokine gene expression in skin of susceptible guinea pigs infected with Treponema pallidum. Immunology 95:242-247.
308. Wicher V, Wicher K, Abbruscato F, Auger I, Rudofsky U. 1999. The time-dependent clearance of virulent Treponema pallidum in susceptible and resistant strains of guinea pigs is significantly different. Clin Immunol 91:77-83.
309. Wicher V, Wicher K, Jakubowski A, Nakeeb SM. 1987. Adoptive transfer of immunity to Treponema pallidum Nichols infection in inbred strain 2 and C4D guinea pigs. Infect Immun 55:2502-2508.
310. Wicher V, Zabek J, Wicher K. 1989. Kinetics of pathogen-specific humoral response in Treponema pallidum-infected young and old inbred strain 2 guinea pigs. Clin Exp Immunol 77:144-150.
311. Wicher V, Zabek J, Wicher K. 1991. Pathogen-specific humoral response in Treponema pallidum-infected humans, rabbits, and guinea pigs. J Infect Dis 163:830-836.
312. Widen R, Lee I, Klein T, Friedman H. 1983. Blastogenic responsiveness of spleen cells from guinea pigs sensitized to Legionella pneumophila antigens. Proc Soc Exp Biol Med 173:547-552.
313. Williams A, Lever MS. 1995. Characterisation of Legionella pneumophila antigen in urine of guinea pigs and humans with Legionnaires' disease. J Infect 30:13-16.
314. Winn WC Jr, Chandler FW. 1982. Role of virulence factors in Legionella infections. Arch Pathol Lab Med 106:105-107.
315. Winn WC Jr, Davis GS, Gump DW, Craighead JE, Beaty HN. 1982. Legionnaires' pneumonia after intratracheal inoculation of guinea pigs and rats. Lab Invest 47:568-578.
316. Wolz C, Goerke C, Landmann R, Zimmerli W, Fluckiger U. 2002. Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect Immun 70:2758-2762.
317. Wong KH, Schalla WO, Arko RJ, Bullard JC, Feeley JC. 1979. Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine. Ann Intern Med 90:634-638.
318. Xiong X, Morita CT, Bukowski JF, Brenner MB, Dascher CC. 2004. Identification of guinea pig γδ T cells and characterization during pulmonary tuberculosis. Vet Immunol Immunopathol 102:33-44.
319. Yamada H, Udagawa T, Mizuno S, Hiramatsu K, Sugawara I. 2005. Newly designed primer sets available for evaluating various cytokines and iNOS mRNA expression in guinea pig lung tissues by RT-PCR. Exp Anim 54:163-172.
320. Yamamoto C, Yoshida S, Taniguchi H, Qin MH, Miyamoto H, Mizuguchi Y. 1993. Lipopolysaccharide and granulocyte colony-stimulating factor delay neutrophil apoptosis and ingestion by guinea pig macrophages. Infect Immun 61:1972-1979.
321. Yamamoto T, Jeevan A, Ohishi K, Nojima Y, Umemori K, Yamamoto S, McMurray DN. 2002. A new assay system for guinea pig interferon biological activity. J Interferon Cytokine Res 22:793-797.
322. Yamamoto Y, Klein TW, Newton CA, Widen R, Friedman H. 1987. Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures. Infect Immun 55:1369-1374.
323. Yang D, Nakada-Tsukui K, Ohtani M, Goto R, Yoshimura T, Kobayashi Y, Watanabe N. 2001. Identification and cloning of genes associated with the guinea pig skin delayed-type hypersensitivity reaction. J Biochem 129:561-568.
324. Yomogida S, Nagaoka I, Saito K, Yamashita T. 1996. Evaluation of the effects of defensins on neutrophil functions. Inflamm Res 45:62-67.
325. Yomogida S, Nagaoka I, Yamashita T. 1996. Purification of the 11-and 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch Biochem Biophys 328:219-226.
326. Yomogida S, Nagaoka I, Yamashita T. 1997. Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and defensins. Comp Biochem Physiol B Biochem Mol Biol 116:99-107.
327. Yoshida S, Mizuguchi Y. 1986. Multiplication of Legionella pneumophila Philadelphia 1 in cultured peritoneal macrophages and its correlation to susceptibility of animals. Can J Microbiol 32:438-442.
328. Yoshimura T, Johnson DG. 1993. cDNA cloning and expression of guinea pig neutrophil attractant protein 1 (NAP1). NAP1 is highly conserved in guinea pig. J Immunol 151:6225-6236.
329. Zhang X, McMurray DN. 1998. Suppression of lymphoproliferation by alveolar macrophages in the guinea pig. Tuber Lung Dis 79:119-126.
330. Zhao J, Wicher V, Burger R, Schafer H, Wicher K. 1992. Strain- and age-associated differences in lymphocyte phenotypes and immune responsiveness in C4-deficient and Albany strains of guinea pigs. Immunology 77:165-170.
331. Zimmerli W. 1993. Experimental models in the investigation of device-related infections. J Antimicrob Chemother 31 Suppl D:97-102.
332. Zimmerli W, Lew PD, Waldvogel FA. 1984. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 73:1191-1200.
333. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. 1982. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 146:487-497.
334. Zimmerli W, Zak O, Vosbeck K. 1985. Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 17:303-310.